Showing: 11 - 20 of 29 RESULTS

Global Phased Array Ultrasonic Transducer Market to Surpass US$ 729.1 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global phased array ultrasonic transducer market is estimated to be valued at US$ 525.6 million in 2020 and is expected to exhibit a CAGR of 4.80 % over the forecast period (2020-2027).

Key Trends and Analysis of the Global Phased Array Ultrasonic Transducer Market:

The global phased array ultrasonic transducer market is expected to show significant growth during the forecast period, owing to key companies focusing on product launches and product approvals to strengthen their position in the phase array ultrasonic transducer market. For instance, in 2017, Alpinion Medical Systems, one of South Korea’s global medical device manufacturers, launched E-CUBE 8, a smart, reliable medical device product with developed convex and phased array transducers of PowerView technology used for high performance with high quality medical imaging and multi-purpose utility in medical imaging.

Moreover, increasing incidence of heart disease conditions such as heart attack, coronary heart conditions, and hypertension are leading to rising cardiac examinations, which is expected to drive the phase array ultrasonic transducer market growth. For instance, according to the Centers for Disease Control and Prevention report, in 2017, around 2 in 10 deaths are caused due to coronary artery disease in adults less than 65 years old in the U.S. and approximately 1 in 5 people below the age of 65 suffer from silent heart attack.

Among region, North America is expected to register higher growth rate, owing to increasing innovations and development of advanced technology in phased array ultrasonic transducers. For instance, in 2019, Butterfly Network, a medical device company in the U.S., developed an ultrasonic transducer Butterfly IQ, which can be coupled with 10 approved android devices of Samsung and Google pixel. This innovation is changing the traditional way of medical imaging procedures, as Butterfly IQ is a portable ultrasonic medical device, which has enhanced compatibility with android phones, thus allowing greater accessibility for healthcare professionals.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4212

Key Market Takeaways:

The global phased array ultrasonic transducer market is expected to exhibit a CAGR of 4.80 % over the forecast period, owing to increasing product launches, product approvals, and rising innovation in development of advanced technology in phased array ultrasonic transducer medical imaging procedures

Competitive Landscape:

Key players operating in the global phase array ultrasonic transducer market include B K Medical Systems Inc, Koninklijke Philips N.V., GE Healthcare, Spacelabs Healthcare, SonoScape Medical Corp, Edan Instruments Inc, Samsung Healthcare, Mindray Medical International Limited, Esaote, FUJIFILM Medical Systems, Siemens Healthineers AG, Canon Medical Systems Corporation, and Butterfly Network Inc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4212

Market Segmentation:

  • Global Phased Array Ultrasonic Transducers, By Type:

    • Linear Array

    • Annular Array

    • Circular Array

  • Global Phased Array Ultrasonic Transducers, By Application:

    • Cardiovascular

    • Neurological

    • Renal

    • Gynecology

    • Others

  • Global Phased Array Ultrasonic Transducers, By End User:

  • Global Phased Array Ultrasonic Transducers, By Region:

    • North America

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Rest of Europe

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

Breast Biopsy Device Market| Growing Prevalence of Breast Cancer Cases to Boost the Market Growth

The global breast biopsy device market size is poised to grow by USD 504.94 million during 2020-2024, progressing at a CAGR of about 10% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Download a Free Sample of REPORT with COVID-19 Crisis and Recovery Analysis.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005108/en/

Technavio has announced its latest market research report titled Global Breast Biopsy Devices Market 2020-2024 (Graphic: Business Wire)

The rising incidence rate of breast cancer has been providing significant business growth opportunities to market vendors. Prominent vendors in the market are focusing on expanding their product portfolios and obtaining approvals for their offerings. They have been leveraging various platforms such as conferences to gain exposure and increase awareness about breast cancer. Furthermore, various governments and private organizations are providing funding and grants to vendors to create innovative products with technologically advanced solutions to detect breast cancer at early stages. These factors will significantly contribute to the market growth over the forecast period.

Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform

Report Highlights:

  • The major breast biopsy device market growth came from the biopsy needles and systems segment. Breast biopsy needles are primarily used for collecting breast tissue from the suspicious areas of the breast during a breast biopsy. Needle biopsies are majorly performed as minimally invasive biopsy procedures for a better assessment of breast cancer in an outpatient setting. The need for highly skilled operators to handle imaging modalities and the reduced technical complexities of this method are driving the demand for breast biopsy needles for the extraction of normal tissues for biopsy.

  • North America was the largest breast biopsy devices market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. High technology adoption among the healthcare sector, increasing healthcare expenditure, the prevalence of breast cancer, and awareness among patients about mammograms that helps to identify breast cancer incidence will significantly drive breast biopsy devices market growth in this region over the forecast period.

  • The global breast biopsy device market is concentrated. Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG are some of the major market participants. To help clients improve their market position, this breast biopsy device market forecast report provides a detailed analysis of the market leaders.

  • As the business impact of COVID-19 spreads, the breast biopsy device market 2020-2024 is expected to have Positive and Superior growth. As the pandemic spreads in some regions and plateaus in other regions, we reevaluate the impact on businesses and update our report forecasts.

Read the

Allergy Immunotherapies Market – Actionable Research on COVID-19 | Increasing Prevalence of Allergies to Boost the Market Growth

The global allergy immunotherapies market size is poised to grow by USD 626.77 million during 2020-2024, progressing at a CAGR of about 7% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Download a Free Sample of REPORT with COVID-19 Crisis and Recovery Analysis.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201007005629/en/

Technavio has announced its latest market research report titled Global Allergy Immunotherapies Market 2020-2024 (Graphic: Business Wire).

The increasing prevalence of allergies is driving the need for allergy immunotherapies. Allergies are regarded as one of the most common ailments, affecting more than 500 million people around the world. The rising incidence of allergy is triggered by factors such as the growing pollution and increased consumption of tobacco products like cigarettes. Moreover, a large portion of people are affected multiple times due to the non-remissive nature of the allergy. The huge unmet need for allergy treatment globally has led to various vendors conducting research on novel therapies, resulting in advances in the field of immunology therapeutics for allergies.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Report Highlights:

  • The major allergy immunotherapies market growth came from SCIT segment. It was the largest product segment of the allergy immunotherapies market in 2019, mainly because of the high efficiency for the treatment of various respiratory allergies. Additionally, SCITs are administered in simple and standardized doses, and they result in long-lasting symptom relief. Thus, contributing to the growth of the market in focus.

  • Europe had the largest allergy immunotherapies market share in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The high prevalence of allergies will significantly influence allergy immunotherapies market growth in this region.

  • The global allergy immunotherapies market is concentrated. Aimmune Therapeutics Inc., ALK-Abelló AS, Allergy Therapeutics Plc, ASIT Biotech SA, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., Laboratorios LETI SLU, Merck KGaA, and Stallergenes Greer Plc. are some of the major market participants. To help clients improve their market position, this allergy immunotherapies market forecast report provides a detailed analysis of the market leaders.

  • As the business impact of COVID-19 spreads, the global allergy immunotherapies market 2020-2024 is expected to have Neutral and At par growth. As the pandemic spreads in some regions and plateaus in other regions, we revaluate the impact on businesses and update our report forecasts.

Read the full report here: https://www.technavio.com/report/report/allergy-immunotherapies-market-industry-analysis

Presence of a Strong Pipeline for Allergy Immunotherapy and the Estimated New Approvals will be a Key Market Trend

The strong efficacy and relatively higher safety of allergy immunotherapies combined with a strong prevalence of various allergies create an attractive opportunity for the market players. Hence, several pharmaceutical and biotechnology

Allergy Rhinitis Drugs Market – Actionable Research on COVID-19 | Growing Awareness about Allergic Rhinitis to Boost the Market Growth

The global allergy rhinitis drugs market size is poised to grow by USD 2.4 billion during 2020-2024, progressing at a CAGR of almost 4% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Download a Free Sample of REPORT with COVID-19 Crisis and Recovery Analysis

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201007005668/en/

Technavio has announced its latest market research report titled Global Allergy Rhinitis Drugs Market 2020-2024 (Graphic: Business Wire)

This growing awareness about allergic rhinitis has proved critical in helping patients get treated in the early stages of the disease. It also increases the chances of accurate diagnosis by physicians. Globally, the prevalence of allergic rhinitis has increased, and there is an increase in the number of initiatives to increase awareness about the disease.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Report Highlights:

  • The major allergy rhinitis drugs market growth came from the Antihistamines segment. They are increasingly being used as a first-line approach to prevent or relieve the symptoms of allergic rhinitis. One of the major factors associated with market growth in this segment is the growing number of companies investing in the development of intranasal antihistamines for the treatment of allergic rhinitis.

  • North America was the largest allergy rhinitis drugs market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The growing prevalence of allergic rhinitis and the availability of a wide range of drugs for the treatment of rhinitis allergy will significantly influence allergy rhinitis drugs market growth in this region.

  • The global allergy rhinitis drugs market is fragmented. Alcon Inc., ALK-Abello AS, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Stallergenes Greer Ltd. are some of the major market participants. To help clients improve their market position, this allergy rhinitis drugs market forecast report provides a detailed analysis of the market leaders.

  • As the business impact of COVID-19 spreads, the global allergy rhinitis drugs market 2020-2024 is expected to have Neutral and At par growth. As the pandemic spreads in some regions and plateaus in other regions, we revaluate the impact on businesses and update our report forecasts.

Read the full report here: https://www.technavio.com/report/report/allergy-rhinitis-drugs-market-industry-analysis

Increasing Demand for Over-The-Counter Medicines will be a Key Market Trend

Patients with mild allergies often self-medicate with over-the-counter drugs.These over-the-counter pills that do not require a written prescription from a healthcare professional can be directly purchased from pharmacies. In addition, these over-the-counter drugs have increased the practice of self-medication among individuals. Self-medication also reduces the pressure of medical services. Therefore, patients are inclined toward over-the-counter drugs, which in turn positively impacts the market.

Technavio’s sample reports

Global Collagen Filler Market to surpass US$ 648.1 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global collagen filler market is estimated to be valued at US$ 648.1 million in 2020 and is expected to exhibit a CAGR of 7.4 % during the forecast period (2020-2027).

Key Trends and Analysis of the Global Collagen Filler Market:

Key companies are focusing on research and development activity and technological advancement in collagen filler is expected to drive the global collagen filler market growth. For instance, in September 2020, CollPlant, an aesthetic medicine company, presented the overview of a plant-derived recombinant human collagen for anti-ageing therapies at the Science of Aging Virtual Symposium 2020 which is a symposium event for showcasing innovation in the field of aesthetic medicine.

Moreover, increasing cosmetic procedures such as face lifts, wrinkle removal, breast augmentation, and lip treatments are expected to drive the global collagen filler market growth. For instance, according to American Society of Plastic Surgeons Report 2020, in 2019, 123,685 face lift procedures and around 37% of soft filler injection were used for treatment of various skin conditions such as skin ageing, wrinkles and face lift procedures across the globe.

Furthermore, various initiatives have been taken by regulating bodies to ensure efficient use to synthetic and cosmetics products for safer use of dermal fillers and to avoid side effects. For instance, in 2018, the US Food Drug and Administration approved temporary/absorbable dermal fillers for correction of moderate to severe face wrinkles, skin folds and unapproved dermal fillers for breast augmentation, size of buttocks, enhance fullness of feet and dermal implants into the bone, tendon, ligament and muscle.

Among regions, the North America market is expected to register highest market share owing to an increase in plastic surgery procedures such as face rejuvenations, lip treatments and temporary procedures such as face line corrections. According to the American Society of Plastic Surgeons report of May 2020, 1.8 million plastic surgeries were performed by certified plastic surgeons in 2018.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4209

Key Market Takeaways:

The global collagen filler market is expected to exhibit a CAGR of 7.4% during the forecast period owing to increasing on research and development along with technological advancement in collagen fillers along with increasing number of cosmetic procedures such as face lifts, wrinkle removal, face rejuvenation and lip treatments.

Competitive Landscape:

Key players operating in the global collagen filler market are Allergan, Inc., Johnson & Johnson, Collplant Holdings Ltd, Ortho Dermatologics, Inc., Suneva Medical, Inc., Merz Pharma GmbH & Co. KGaA, Surgical Specialties Corporation, Sinclair Pharma, Inamed GmbH, and Endo International plc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4209

Market Segmentation:

Related Market Intelligence Report:

Ischemia Reperfusion Injury Therapeutics Market, by Indication (Heart Injury, Kidney Injury, Intestine Injury, and Other Injury), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/ischemia-reperfusion-injury-therapeutics-market-4105

About Us:

Coherent Market Insights is a global market intelligence and

Europe Animal Healthcare Market to Surpass US$ 17,837.8 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the Europe animal healthcare market is estimated to be valued at US$ 13,119.7 million in 2020 and is expected to exhibit a CAGR of 4.5% over the forecast period (2020-2027).

Key Trends and Analysis of the Europe Animal Healthcare Market:

Key trends in the market are rising incidence of zoonotic viral pathogens, increasing demand for protein from animal sources, and government initiatives to provide improved animal healthcare.

Market players are focused on launches and approvals of products for better offerings in the market. For instance, in August 2017, Boehringer Ingelheim launched Centragard, a transdermal solution for the treatment and control of three most common intestinal parasites in cats such as hookworms, roundworms, and tapeworms.

Increasing adoption of various growth strategies by market players such as investments in order to maintain a competitive edge in the market is expected to drive the market growth. For instance, in July 2018, Boehringer Ingelheim announced investment of around US$ 221 million for establishing a production center to cater to the increasing demand for drugs of foot-and-mouth disease and Bluetongue virus.

The most common zoonotic viral diseases diagnosed in Europe over the past few years include rabies, influenza virus, Rift Valley fever, dengue fever, West Nile fever, crimean-congo hemorrhagic fever, and others. According to the HealthforAnimals Association, around 60% of diseases in the world are zoonotic, which are responsible for 2.4 billion cases of human illnesses and 2.2 million deaths, annually.

Furthermore, companies and the subsidiaries operating in the Europe intend to leverage their proprietary technologies for the development of novel therapeutics to treat serious medical conditions in pets. For instance, in 2017, OPKO Health Spain evaluated Enko 1 for use in companion animals. Enko 1 is a patented intra-articular injectable hyaluronic acid and chondroitin sulfate complex to relieve pain.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/550

However, stringent regulations on sales and usage of antibiotics, and high cost of animal healthcare services are major factors hindering the market growth. Antimicrobial resistance (AMR) is a major concern limiting the usage of antibiotics, which has resulted in lesser use of antibiotics. In 2015, the Europe government published guidelines regarding the proper use of antimicrobial agents in veterinary medicine to control AMR in animals, which has led to various restrictions.

Key Market Takeaways:

The Europe animal healthcare market is expected to exhibit a CAGR of 4.5% over the forecast period, owing to rising incidence of zoonotic viral pathogens, increasing demand for protein from animal sources, increasing government initiatives to provide improved animal healthcare, and adoption of inorganic growth strategies such as acquisitions and collaborations by market players. For instance, in February 2019, UNION Therapeutics A/S and Ceva Santé Animale S.A. partnered for the development of UNI836 for treating canine pyoderma in companion animals.

Key players in the market are focused on product approvals and launches to enhance their product portfolio, which in turn is expected to propel the market growth over the forecast period. For instance, in September 2015,

Cottonseed Oil Market – Actionable Research on COVID-19 | Use of Cottonseed Oil by End-users to Boost the Market Growth

The global cottonseed oil market size is poised to grow by 782.02 K tons during 2020-2024, progressing at a CAGR of almost 3% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Download a Free Sample of REPORT with COVID-19 Crisis and Recovery Analysis.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201005005962/en/

Technavio has announced its latest market research report titled Global Cottonseed Oil Market 2020-2024 (Graphic: Business Wire)

Cottonseed oil has a high smoke point and a neutral taste and is used for deep frying and baking. Cottonseed oil is also a significant ingredient in whipped toppings, margarine, shortenings, spreads, and icings due to its ability to form a beta prime crystal, which enables a consistent texture and appearance. Cottonseed oil is also used for various applications in the cosmetic industry and products such as soaps, cosmetics, and detergents. The increased usage of cottonseed oil across various industries will be one of the major factors that will fuel the growth of this global market.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Report Highlights:

  • The major cottonseed oil market growth came from GM cottonseed oil segment. This segment accounted for the largest market share in 2019. However, due to factors such as the increasing concern among the consumers about the harmful effects of GM cottonseed oil, the forecast period will witness a decrease in the segment’s cottonseed oil market share.

  • APAC was the largest cottonseed oil market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. Factors such as the increasing use of biodiesel will significantly drive cottonseed oil market growth in this region over the forecast period.

  • The global cottonseed oil market is fragmented. Archer Daniels Midland Co., Bunge Ltd., Cargill Inc., Henry Lamotte Oils GmbH, ITOCHU Corp., Marico Ltd., PYCO Industries, Ruchi Soya Industries Ltd., Vimal Oil & Foods Ltd., and Wilmar International Ltd. are some of the major market participants. To help clients improve their market position, this cottonseed oil market forecast report provides a detailed analysis of the market leaders.

  • As the business impact of COVID-19 spreads, the global cottonseed oil market 2020-2024 is expected to have Positive and Superior. As the pandemic spreads in some regions and plateaus in other regions, we revaluate the impact on businesses and update our report forecasts.

Read the full report here: https://www.technavio.com/report/report/cottonseed-oil-market-industry-analysis

Growing Popularity of Organic Cottonseed Oil will be a Key Market Trend

The growing popularity of organic cottonseed oil is one of the key cottonseed oil market trends that will influence market growth. There is an increasing awareness among consumers about the benefits of organic food, and this is resulting in the increased consumption of

Home Fitness Equipment Market – Actionable Research on COVID-19 | Increasing Awareness about Fitness to Boost the Market Growth

The Daily Beast

Photos Show Why Miami Public Schools Could Be the Next Ron DeSantis Coronavirus Debacle

MIAMI—Last week, a few days before Donald Trump revealed he came down with COVID-19, Karla Hernandez-Mats went on a coronavirus safety fact-finding mission in South Florida schools ahead of their reopening on Monday.The president of United Teachers of Dade, the local teachers union, Hernandez-Mats said she and her colleagues conducted surprise inspection visits at 17 Miami-area schools that suggested administrators were still scrambling to put safety measures in place.At Miami Springs Senior High, one of the 17 schools inspected, administrators initially refused to allow her colleague, United Teachers of Dade First Vice-President Antonio White, to enter the building and called a police resource officer on him, the union officials told The Daily Beast.“When administrators act like that, their schools are usually not prepared,” White said in an interview. “That was the case at Miami Springs.”COVID-Skeptical Florida Guv Outdoes Himself, Lifts All Restrictions on Restaurants and BarsFor instance, the school appears to be supplying teachers with alcohol-free hand sanitizer, which may be ineffective in killing coronavirus, the union officials said, providing The Daily Beast with a photo of just that. (The Centers for Disease Control’s COVID-19 guidance recommends people use hand sanitizer that is at least 60 percent ethanol-based or 70 percent isopropanol-based.) Union officials also provided photos showing decals marking 6-foot distance requirements that were already peeling off the sidewalks near the school’s entrance, and desks arranged in such a way that does not allow for 6-foot social distancing.Reached by phone, Miami Springs principal Torossian said he was unaware of police being called on the union official and referred further questions to the school district’s media relations department. Spokeswoman Jacquelyn Calzadilla did not specifically address what had occurred at Miami Springs, but she said “our school site administrators are working around the clock to ensure a safe return to the schoolhouse for our students and employees.”The flap illustrates the daunting task facing the public school system in Miami-Dade County, which has been the epicenter of Florida’s COVID-19 outbreak for most of the pandemic. More than 10,000 teachers and 133,000 students begin filing into 340 schools this week on a staggered schedule. This after the Miami-Dade School Board voted to resume in-person learning under pressure from Florida Education Commissioner Richard Cocoran, a Gov. Ron DeSantis appointee who threatened to cut the school district’s funding if classes did not resume by early October.Miami-Dade’s daily positivity rate rolling average for the 14 days ending on Oct. 4 stood at 4.78 percent, just below the 5 percent positivity rate that the World Health Organization recommends maintaining for two weeks before lifting shelter-at-home and social distancing protocols. During the same 14-day period, Miami-Dade reported 5,456 new cases, bringing its total to 172,205.School reopenings have been a mess of infection, quarantine, and closure across America in recent weeks. But conversations with teachers, labor leaders, and experts in South Florida painted a picture of Miami schools as a new guinea

Global Anti-aging Treatment Market to Surpass US$ 34.49 Billion by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global anti-aging treatment market is estimated to be valued at US$ 21.06 billion in 2020 and is expected to exhibit a CAGR of 7.3% over the forecast period (2020-2027).

Key Trends and Analysis of the Global Anti-aging Treatment Market:

Key trends in the market include increasing launches of anti-aging treatment products, increasing number of aesthetic procedures, and increasing acquisitions, partnerships, and agreements by key players. These are expected to aid in growth of the market.

According to the 2018 Plastic Surgery Statistics Report by the American Society of Plastic Surgeons, approximately 17.7 million cosmetic procedures were performed in the U.S. in 2018. According to the same source, the top three minimally invasive cosmetic procedures include botulinum toxin type A, soft tissue fillers, and chemical peel.

Moreover, key players are focusing on raising finances through investments by private equity platform in order to enhance their market presence, which is expected to drive growth of the anti-aging treatment market over the forecast period. For instance, in May 2018, Rodan + Fields, LLC, a U.S.-based skincare brand, announced that TPG Capital, an American investment company, invested in Rodan + Fields, LLC. The investment through TPG Capital will provide Rodan + Fields, LLC with an access to better business building expertise in order to expand its business domestically and internationally.

Furthermore, increasing product launches by key players is expected to propel the market growth over the forecast period. For instance, in January 2019, T.A. Sciences, a provider of clinically tested wellness products, launched T.A.-65, an anti-oxidant formula, developed for reducing the visible signs of aging, evening out discolored and blotchy skin tones, increasing skin firmness and tone, and diminishing facial wrinkles and folds.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4210

Key Market Takeaways:

The global anti-aging treatment market is expected to exhibit a CAGR of 7.3% over the forecast period. This is owing to increasing number of aesthetic procedures. According to the International Society of Aesthetic Plastic Surgery, around 227,089 facial rejuvenation procedures were performed in Japan in 2017.

Among regions, North America is expected to hold dominant position in the global market over the forecast period, owing to high presence of key players such as NuFACE and Alma Laser, and rising number of minimally invasive cosmetic procedures. According to the International Society of Aesthetic Plastic Surgery, around 1,903,660 non-surgical procedures including botulinum toxin, were performed in the U.S. in 2017.

Key players operating in the global anti-aging treatment market include Allergan Plc, Estée Lauder Companies, Shiseido Company, Beiersdorf AG, L’Oréal S.A, NuFACE, Ostium Cosmetics, PhotoMedex, Inc, Alma Laser, Rodan & Fields, LLC, and others

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4210

Market Segmentation:

  • Global Anti-aging Treatment Market, By Product Type:

  • Global Anti-aging Treatment Market, By Technology:

  • Global Anti-aging Treatment Market, By End User:

    • Hospitals

    • Skin Care Clinics

    • Homecare Settings

    • Others

  • Global Anti-aging Treatment Market, By Region:

    • North America

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Rest

Regenerative Medicine Market Share, Trend, Opportunity, Affect On Demand By COVID-19 Pandemic And Forecast 2020-2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 21, 2020 (AmericaNewsHour) —
Regenerative Medicine Market Analysis
According to Verified Market Research, the Global Regenerative Medicine Market was valued at USD 19.10 Billion in 2018 and is expected to witness a growth of 22.72% from 2019-2026 and reach USD 98.10 Billion by 2026.

What is Regenerative Medicine Market?
The field of regenerative medicine comprises of abundant strategies, which mainly includes use of materials and de novo generated cells, as well as various amalgamations thereof, to substitute the lost tissue, efficiently replacing it both anatomically and functionally, or to contribute to tissue restoration. The main objective of regenerative medicine is to propagate replacement tissue or organs for patients who have sustained an injury or have had a disease that permanently damaged their tissue. National Institutes of Health defines regenerative medicine as a process of creating living, functional tissues to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects.
Regenerative Medicine can be perceived as an interdisciplinary field of research and clinical applications which mainly focuses on the repair, replacement or regeneration of cells, tissues or organs. Regenerative Medicine mainly restores impaired function resulting from any cause. Regenerative medicine has the ability to rectify or substitute tissues and organs impaired by age, disease, or trauma, as well as to normalize congenital defects.

The Final Report will cover the impact analysis of COVID-19 on this industry:

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10085009

Regenerative Medicine Market Outlook
Over the last decade, stem cell biology has experienced a breakthrough in scientific and technological developments that will together have foremost and continuing influence on regenerative medicine. These entails capability to produce pluripotent stem cells from adult body cells and to cultivate mini-organs from these or from adult stem cells in well-defined culture conditions. Both methodologies offer ways to develop functional cells of human tissue that could be used for transplantation and tissue repair.
Government policies favoring regenerative medicine is one of the major reasons which has been driving the market growth. The European Union (EU) and Dutch government have prioritized regenerative medicine as an area of key strategic relevance. Apart from this, rapid increase in aged population has also boomed the market in North American region. The North Carolina Tissue Engineering and Regenerative Medicine Society is an organization in the U.S. working to improve and advance basic research, commercial development and education in the field of regenerative medicine. In the U.S., two major government agencies – NIH and CIRM – gather funds for academic translational stem cell research and regenerative medicine development. Increasing global healthcare expenditure is also expected to fuel the market.

Lack of awareness and ethical issues regarding the use of Embryonic Stem Cell for R&D is expected to hinder the market for regenerative medicine. The market growth rate is highly influenced by the adoption rate of cell therapy in the market, as it is an integral part of regenerative medicine.